In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4+ T cells without MHC restriction

References

1. Adachi A., Ono N., Sakai H., Ogawa K., Shibata R., Kiyomasu T., Masuike H., Ueda S. 1991; Generation and characterization of the human immunodeficiency virus type 1 mutants. Archives of Virology 117:45–58
   [Google Scholar]
2. Arya S. K., Guo C., Josephs S. F., Wong-Staal F. 1985; Transactivator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69–73
   [Google Scholar]
3. Barré-Sinoussi F., Chemman J. C., Rey R., Nugeyre M. T., Chamaret S., Gruest J., Dauget C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rosenbaum W., Montagnier L. 1983; Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871
   [Google Scholar]
4. Coffin J. M. 1995; HIV population dynamics in vivo: implication for genetic variation, pathogenesis, and therapy. Science 267:483–489
   [Google Scholar]
5. de Santis R., Anastasi A. M., Marcolini S., Valesini G., Pezzella M., Vonesch N., Sturchio E., Mele A. 1991; Production of a nef-specific monoclonal antibody by the use of a synthetic peptide. AIDS Research and Human Retroviruses 7:315–321
   [Google Scholar]
6. Edwards S. A., Fan H. 1979; gag-related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms. Journal of Virology 30:551–563
   [Google Scholar]
7. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner- Racz K., Haase A. T. 1993; Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359–362
   [Google Scholar]
8. Foley G. E., Lazarus H., Farber S., Uzman B. G., Boone B. A., McCarthy R. E. 1965; Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522–529
   [Google Scholar]
9. Franchini G., Robert-Guroff M., Ghrayeb J., Chang N. T., Wong- Staal F. 1986; Cytoplasmic localization of the HTLV-III 3′ orf protein in cultured T cells. Virology 144:593–599
   [Google Scholar]
10. Fujii Y., Nishino Y., Nakaya T., Tokunaga K., Ikuta K. 1993; Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells. Vaccine 11:1240–1246
    [Google Scholar]
11. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B., White G., Foster P., Markham P. D. 1984; Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:5000–5003
    [Google Scholar]
12. Harper M. E., Marselle L. M., Gallo R. C., Wong-Staal F. 1986; Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proceedings of the National Academy of Sciences, USA 83:772–776
    [Google Scholar]
13. Heinkelein M., Sopper S., Jassoy C. 1995; Contact of human immunodeficiency virus type 1-infected and uninfected CD4⁺ T lymphocytes is highly cytolytic for both cells. Journal of Virology 69:6925–6931
    [Google Scholar]
14. Ho D. D., Heumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. 1995; Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123–126
    [Google Scholar]
15. Hussey R. E., Richardson N. E., Kowalski M., Brown N. R., Chang H. C., Siliciano R. F., Dorfman T., Walker B., Sodroski J., Reinherz E. L. 1988; A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature 331:78–81
    [Google Scholar]
16. Kearney J. F., Radbruch A., Liesebang B., Rajewsky K. 1979; A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. Journal of Immunology 123:1548–1550
    [Google Scholar]
17. Kienzle N., Bachmann M., Müller W. E. G., Müller-Lantzsch N. 1992; Expression and cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells. Archives of Virology 124:123–132
    [Google Scholar]
18. Kikukawa R., Koyanagi Y., Harada S., Kobayashi N., Hatanaka M., Yamamoto N. 1986; Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. Journal of Virology 57:1159–1162
    [Google Scholar]
19. King L. A., Possee R. D. 1992; The development of baculovirus expression vectors. In The Baculovirus Expression System Edited by King L. A., Possee R. D. London: Chapman and Hall;
    [Google Scholar]
20. Ledbetter J. A. 1979; Two-dimensional analysis of murine leukemia virus gag-gene polyproteins. Virology 95:85–98
    [Google Scholar]
21. Levy J. A., Hoffman A. D., Kramer S. M., Landis J. A., Shimabukuro J. M., Oskiro L. S. 1984; Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840–842
    [Google Scholar]
22. Lozzio C. B., Lozzio B. B. 1975; Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321–322
    [Google Scholar]
23. Matsuura Y., Possee R. D., Overton H. A., Bishop D. H. L. 1987; Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. Journal of General Virology 68:1233–1250
    [Google Scholar]
24. Meyaard L., Otto S. A., ionker R. R., Mijnster M. J., Keet R. P. M., Miedema F. 1992; Programmed death of T cells on HIV-1 infection. Science 257:217–219
    [Google Scholar]
25. Miedema F., Tersmette M., van Lier R. A. W. 1990; AIDS pathogenesis: a dynamic interaction between HIV and the immune system. Immunology Today 11:293–297
    [Google Scholar]
26. Minowada J., Ohnuma T., Moore G. E. 1972; Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. Journal of the National Cancer Institute 49:891–895
    [Google Scholar]
27. Otake K., Jujii K. Y., Nakaya T., Nishino Y., Zhong Q., Fujinaga K., Kameoka M., Ohki K., Ikuta K. 1994; The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4⁺ T cells. Journal of Immunology 153:5826–5837
    [Google Scholar]
28. Overton H. A., Fujii Y., Price I. R., Jones I. M. 1989; The protease and gag gene products of the human immunodeficiency virus: authentic cleavage and post-translational modification in an insect cell expression system. Virology 170:107–116
    [Google Scholar]
29. Ovod V., Lagerstedt A., Ranki A., Gombert F. O., Spohn R., Tähtinen M., Jung G., Krohn K. J. E. 1992; Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS 6:25–34
    [Google Scholar]
30. Pandori M. W., Fitch N. J. S., Craig H. M., Richman D. D., Spina C. A., Guatelli J. C. 1996; Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. Journal of Virology 70:4283–4290
    [Google Scholar]
31. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. 1984; Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
    [Google Scholar]
32. Pulvertaft R. J. V. 1965; A study of malignant tumors in Nigeria by short term tissue culture. Journal of Clinical Pathology 18:261–273
    [Google Scholar]
33. Ralph P., Moore M. A. S., Nilsson K. 1976; Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. Journal of Experimental Medicine 143:1528–1533
    [Google Scholar]
34. Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A. Jr, Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R., Pearson M. L., Lautenberger J. A., Papas T. S., Ghrayeb J., Chang N. T., Gallo R. C., Wong-Staal F. 1985; Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313:277–284
    [Google Scholar]
35. Sanchez-Pescador R., Power M. D., Barr P. J., Steimer K. S., Stempien M. M., Brown-Shimer S. L., Gee W. W., Renard A., Randolph A., Levy J. A., Dina D., Luciw P. A. 1985; Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science 227:484–492
    [Google Scholar]
36. Schneider U., Shwenk H.-U., Bornkamm G. 1977; Characterization of EBV-genome negative ‘Null’ and ‘T’ cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non- Hodgkin’s lymphoma. International Journal of Cancer 19:621–626
    [Google Scholar]
37. Schnittman S. M., Psallidopoulos M. C., Lane H. C., Thompson L., Baseler M., Massari F., Fox C. H., Salzman N. P., Fauci A. S. 1989; The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305–308
    [Google Scholar]
38. Slezak S. E., Horan P. K. 1989; Cell-mediated cytotoxicity. A highly sensitive and informative flow cytometric assay. Journal of Immunological Methods 117:205–214
    [Google Scholar]
39. Subbramanian R. A., Cohen E. A. 1994; Molecular biology of the human immunodeficiency virus accessory proteins. Journal of Virology 68:6831–6835
    [Google Scholar]
40. Trono D. 1995; HIV accessory proteins: leading roles for the supporting cast. Cell 82:189–192
    [Google Scholar]
41. Wain-Hobson S., Sonigo P., Danos O., Cole S., Alzon M. 1985; Nucleotide sequence of the AIDS virus Lav. Cell 40:9–17
    [Google Scholar]
42. Weiss R. A. 1993; How does HIV cause AIDS?. Science 260:1273–1279
    [Google Scholar]
43. Wells D. E., Chatterjee S., Mulligan M. J., Compans R. W. 1991; Inhibition of human immunodeficiency virus type 1-induced cell fusion by recombinant human interferons. Journal of Virology 65:6325–6330
    [Google Scholar]
44. Yu G., Felsted R. L. 1992; Effect of myristoyiation on p2 7nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187:46–55
    [Google Scholar]
45. Yunoki M., Maotani-lmai K., Kusuda H., Motoyama M., Miyake S., Imai K. H., Shin Y. S., Kato S., Sano K., Morita C., Nakai M., Hirai K., Ikuta K. 1991; Production of infectious particles from defective human immunodeficiency virus type 1 (HlV-1)-producing cell clones by superinfection with infectious HIV-1. Archives of Virology 116:143–158
    [Google Scholar]